Grandma's House

First it was Vioxx, then Celebrex. Now the shadow of heart problems is hovering over Aleve, also known as naproxen.

A study testing whether Celebrex or naproxen would reduce the risk of Alzheimer's disease was halted Monday after researchers noted an increase in heart attack and stroke among participants who were taking naproxen, an over-the-counter pain reliever on the market for nearly 30 years.

Officials at the National Institute of Health said the study was stopped after three years when it was noticed that patients taking naproxen, sold under the brand name Aleve, had a 50 percent greater incidence of cardiovascular events — heart attack or stroke — than patients taking placebo.

I guess we can expect to be inundated with another round of lawyers advertising for clients to build a class-action suit against the manufacturer. You know it's going to happen.